Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?
10.1016/j.pharmthera.2022.108153
Saved in:
Main Authors: | Heng, CKM, Gilad, N, Darlyuk-Saadon, I, Wong, WSF, Engelberg, D |
---|---|
Other Authors: | MICROBIOLOGY AND IMMUNOLOGY |
Format: | Review |
Published: |
Elsevier BV
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229044 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Activation of protein kinases and the inactivation of protein phosphatase 2A in tumour necrosis factor and interleukin-1 signal-transduction pathways
by: Guy, G.R., et al.
Published: (2011) -
EXPLORING SPECIFIC P38α ACTIVATION AND ITS EFFECT ON LUNG PHYSIOLOGY AND PATHOLOGY
by: MATTHEW HENG CHEW KIAT
Published: (2022) -
Osmostress Induces Autophosphorylation of Hog1 via a C-Terminal Regulatory Region That Is Conserved in p38?
by: Maayan I., et al.
Published: (2019) -
Expression of a constitutively active p38α mutant in mice causes early death, anemia, and accumulation of immunosuppressive cells
by: Darlyuk-Saadon, I, et al.
Published: (2022) -
Thrombopoietin (TPO) induces C-MYC expression through a PI3K-dependent pathway that is not mediated by AKT, PKC, or MTOR in TPO-dependent cell lines and primary megakaryocytes
by: Supantitra Chanprasert
Published: (2023)